The moving party physician sought an order under s. 19 of the Health Care Consent Act to authorize treatment of the respondent with clozapine pending her appeal of a Consent and Capacity Board decision.
The respondent, who suffers from treatment-resistant schizophrenia and exhibits violent and hyper-sexual behaviour, opposed the motion.
The court addressed evidentiary issues, admitting some hearsay in medical records and accepting the treating psychiatrist as a participant expert.
The court found that the statutory criteria were met, as clozapine was likely to substantially improve her condition, the benefits outweighed the risks, it was the least restrictive option, and her deteriorating condition made treatment necessary before the appeal.